Cholesterol metabolism is altered in Rett syndrome: A study on plasma and primary cultured fibroblasts derived from patients

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Segatto, Marco ^a   Trapani, Laura ^a   Di Tunno, Ilenia ^a   Sticozzi, Claudia ^b   Valacchi, Giuseppe ^b   Hayek, Joussef ^c   Pallottini, Valentina ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MECP2 PROTEIN, HUMAN; MECP2 PROTEIN, MOUSE; METHYL CPG BINDING PROTEIN 2; PCSK9 PROTEIN, HUMAN; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B; SERINE PROTEINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ADOLESCENT; ADULT; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CHILD; DEFICIENCY; FEMALE; FIBROBLAST; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; MUTATION; PRESCHOOL CHILD; RETT SYNDROME; YOUNG ADULT;

ADOLESCENT; ADULT; ANIMALS; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; FEMALE; FIBROBLASTS; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MUTATION; PROPROTEIN CONVERTASES; RECEPTORS, LDL; RETT SYNDROME; SCAVENGER RECEPTORS, CLASS B; SERINE ENDOPEPTIDASES; STEROL REGULATORY ELEMENT BINDING PROTEINS; YOUNG ADULT;

EID: 84905844155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104834     Document Type: Article

References (33)

1. Patankar JV (2014) Cholesterol metabolism is a potential therapeutic target for Rett syndrome. Clin Genet 85: 229-230.
2. Rett A (1966) On a unusual brain atrophy syndrome in hyperammonemia in childhood. Wien Med Wochenschr 116: 723-726.
3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188. (Pubitemid 29455390)
4. De Felice C, Signorini C, Leoncini S, Pecorelli A, Durand T, et al. (2012) The role of oxidative stress in Rett syndrome: an overview. Ann N Y Acad Sci 1259: 121-135.
5. Macdonald JL, Verster A, Berndt A, Roskams AJ (2010) MBD2 and MeCP2 regulate distinct transitions in the stage-specific differentiation of olfactory receptor neurons. Mol Cell Neurosci 44: 55-67.
6. Percy AK (2013) Neuroscience. Path to treat Rett syndrome. Science 342: 318-320.
7. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, et al. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229. (Pubitemid 351929512)
8. Ben-Shachar S, Khajavi M, Withers MA, Shaw CA, van Bokhoven H, et al. (2009) Dominant versus recessive traits conveyed by allelic mutations - to what extent is nonsense-mediated decay involved? Clin Genet 75: 394-400.
9. Sticozzi C, Belmonte G, Pecorelli A, Cervellati F, Leoncini S, et al. (2013) Scavenger receptor B1 post-translational modifications in Rett syndrome. FEBS Lett 587: 2199-2204.
10. Buchovecky C, Turley S, Brown H, Kyle S, McDonald J, et al. (2013) A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nature Genetics.
11. Trapani L, Segatto M, Ascenzi P, Pallottini V (2011) Potential role of nonstatin cholesterol lowering agents. IUBMB Life 63: 964-971.
12. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89: 331-340. (Pubitemid 27220877)
13. Poirier S, Mayer G (2013) The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol. Drug Des Devel Ther 7: 1135-1148.
14. Savoldi R, Prandini BD, Donisi C (1976) [Enzymatic determination of total serum cholesterol by 4-aminophenazone-phenol: manual and automatic method (author's transl)]. Quad Sclavo Diagn 12: 238-247.
15. Trinder P, Webster D (1984) Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent. Ann Clin Biochem 21 (Pt 5): 430-433. (Pubitemid 14028924)
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
17. da Rocha JT, Trapani L, Segatto M, La Rosa P, Nogueira CW, et al. (2013) Molecular effects of diphenyl diselenide on cholesterol and glucose cell metabolism. Curr Med Chem.
18. Segatto M, Trapani L, Lecis C, Pallottini V (2012) Regulation of cholesterol biosynthetic pathway in different regions of the rat central nervous system. Acta Physiol (Oxf) 206: 62-71.
19. Brown MS, Goldstein JL (1980) Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21: 505-517. (Pubitemid 11194847)
20. Trapani L, Segatto M, Pallottini V (2013) New compounds able to control hepatic cholesterol metabolism: Is it possible to avoid statin treatment in aged people? World J Hepatol 5: 676-684.
21. Hardie DG, Sakamoto K (2006) AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology (Bethesda) 21: 48-60. (Pubitemid 43752517)
22. Gaussin V, Skarlas P, Ching YP, Hardie DG, Hue L (1997) Distinct type-2A protein phosphatases activate HMGCoA reductase and acetyl-CoA carboxylase in liver. FEBS Lett 413: 115-118. (Pubitemid 27348647)
23. Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, et al. (2006) Rat HMGCoA reductase activation in thioacetamide-induced liver injury is related to an increased reactive oxygen species content. J Hepatol 44: 368-374. (Pubitemid 43069219)
24. Espenshade PJ, Hughes AL (2007) Regulation of sterol synthesis in eukaryotes. Annu Rev Genet 41: 401-427.
25. Horton JD (2002) Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis. Biochem Soc Trans 30: 1091-1095.
26. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47. (Pubitemid 16037973)
27. Segatto M, Di Giovanni A, Marino M, Pallottini V (2013) Analysis of the protein network of cholesterol homeostasis in different brain regions: an age and sex dependent perspective. J Cell Physiol 228: 1561-1567.
28. Segatto M, Manduca A, Lecis C, Rosso P, Jozwiak A, et al. (2014) Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats. Neuropsychopharmacology 39: 841-854.
29. Chen XW, Wang H, Bajaj K, Zhang P, Meng ZX, et al. (2013) SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion. Elife 2: e00444.
30. Bourdon V, Philippe C, Bienvenu T, Koenig B, Tardieu M, et al. (2001) Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications. J Med Genet 38: 867-871.
31. Pfrieger FW (2003) Role of cholesterol in synapse formation and function. Biochim Biophys Acta 1610: 271-280.
32. Pfrieger FW (2002) Role of glia in synapse development. Curr Opin Neurobiol 12: 486-490.
33. Nagy G, Ackerman SL (2013) Cholesterol metabolism and Rett syndrome pathogenesis. Nat Genet 45: 965-967.